Raul Santos: International Collaborative Insights into the Treatment of Homozygous FH
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“The therapy of Homozygous FH (HoFH) is a great challenge due to the extreme elevated LDL-C levels and the genetic variability that characterizes this disease.
Combination therapy is the rule to reduce LDL-C, and is classified in medications that depend on the LDL receptor function like statins, ezetimibe and PCSK9 inhibitors and those who are independent like Lomitapide and Evinacumab.
In this collaborative study between Canada, South Africa and Brazil led by John Mancini we showed that statins also reduce LDL-C by mechanisms other than depending on the LDL receptor alone.
HoFH is a devastating disease that needs to be diagnosed and treated ASAP.
Novel therapies are coming and hopefully will change for good how we treat this disease!”
Article: Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.
Authors: G.B.John Mancini, Arnold Ryomoto, Isabelle Ruel, Iulia Iatan, Jacques Genest, Frederick J. Raal, Raul D. Santos, Ana Paula Marte, Brooke A. Kennedy, Liam R. Brunham, Daniel Gaudet, Miriam Larouche, Diane Brisson, Robert A. Hegele
Read the Full Article on Atherosclerosis
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 19, 2026, 13:38Abdul Mannan: 240 Flashcards on Acquired Underproduction Anemias
-
Feb 19, 2026, 13:36Sarah Mount: Pregnancy, Hypercoagulability, and Erythritol
-
Feb 19, 2026, 13:36Shiny K. Kajal: Cold Agglutinins Can Mimic Macrocytosis on CBC
-
Feb 19, 2026, 13:29Salihu (Oyiza) Asimawu: What If Blood Could Be Prepared in the Lab?
-
Feb 19, 2026, 13:28Augustina Isioma: Quality, Safety, and Clinical Judgment in Every Blood Unit
-
Feb 19, 2026, 13:26Mavis Agnes Kisakye: Raising Awareness of Haemophilia and SCD in Ugandan Schools
-
Feb 19, 2026, 13:19Iryna Yaryhina: Moving Beyond Episomal Fixes Toward Genomic Durability for Hemophilia
-
Feb 19, 2026, 13:13Alan Nurden: Angiodysplasia and Gastrointestinal Bleeding in Von Willebrand Disease
-
Feb 19, 2026, 13:06EAHAD Welcomes Giancarlo Castaman to VWD Working Group